Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis

References

• Xia Wang CP, Gong J, Liu X, et al. Enhancing the enrichment of Pharmacophore-Based target prediction for the polypharmacological profiles of drugs. J Chem Inf Model. 2016;56(1):1–9. doi: 10.1007/s40257-019-00483-1.
   PubMedGoogle Scholar
• Kennedy PGE, Mogensen TH, Cohrs RJ. Recent issues in varicella-zoster virus latency. Viruses. 2021;13(10):2018. doi: 10.3390/v13102018.
   PubMed Web of Science ®Google Scholar
• Gruver C, Guthmiller KB. Postherpetic neuralgia. Treasure Island (FL): StatPearls Publishing LLC; 2023.
   Google Scholar
• Tayyar R, Ho D. Herpes simplex virus and varicella zoster virus infections in cancer patients. Viruses. 2023;15(2):439. doi: 10.3390/v15020439.
   PubMed Web of Science ®Google Scholar
• MacDougall C, Guglielmo BJ. Pharmacokinetics of valaciclovir. J Antimicrob Chemother. 2004;53(6):899–901. doi: 10.1093/jac/dkh244.
   PubMed Web of Science ®Google Scholar
• De Clercq E. The development of BVDU: an odyssey. Antivir Chem Chemother. 2023;31:20402066231152971. doi: 10.1177/20402066231152971.
   Google Scholar
• Kaikai SM, Dowling Evans D. Presentation, management, and prevention of herpes zoster. Adv Emerg Nurs J. 2022;44(1):3–10. doi: 10.1097/tme.0000000000000395.
   PubMed Web of Science ®Google Scholar
• Vogel C, Wetzel L, Wutzler P, et al. Treatment with brivudine in immunocompromised pediatric patients with herpes zoster. Chemotherapy. 2023;68(4):222–227. doi: 10.1159/000531034.
   PubMed Web of Science ®Google Scholar
• Kim SH. Current scenario and future applicability of antivirals against herpes zoster. Korean J Pain. 2023;36(1):4–10. doi: 10.3344/kjp.22391.
   PubMed Web of Science ®Google Scholar
• Wassilew S. Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study. J Eur Acad Dermatol Venereol. 2005;19(1):47–55. doi: 10.1111/j.1468-3083.2004.01119.x.
   PubMed Web of Science ®Google Scholar
• Yaldiz M, Solak B, Kara RO, et al. Comparison of famciclovir, valaciclovir, and brivudine treatments in adult immunocompetent patients with herpes zoster. Am J Ther. 2018;25(6):e626–e634. doi: 10.1097/mjt.0000000000000436.
   PubMed Web of Science ®Google Scholar
• Zeng X, Jiang J, Liu S, et al. Bidirectional effects of geniposide in liver injury: preclinical evidence construction based on meta-analysis. J Ethnopharmacol. 2024;319(Pt 1):117061. doi: 10.1016/j.jep.2023.117061.
   PubMedGoogle Scholar
• Yang M, Shen C, Zhu S-J, et al. Chinese patent medicine Aidi injection for cancer care: an overview of systematic reviews and meta-analyses. J Ethnopharmacol. 2022;282:114656. doi: 10.1016/j.jep.2021.114656.
   PubMed Web of Science ®Google Scholar
• Lee YH. An overview of meta-analysis for clinicians. Korean J Intern Med. 2018;33(2):277–283. doi: 10.3904/kjim.2016.195.
   PubMed Web of Science ®Google Scholar
• Tufanaru C, Munn Z, Stephenson M, et al. Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc. 2015;13(3):196–207. doi: 10.1097/xeb.0000000000000065.
   PubMed Web of Science ®Google Scholar
• Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019.
   Google Scholar
• Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for herpes zoster: a survey study on postherpetic neuralgia. Antiviral Res. 2003;59(1):57–60. doi: 10.1016/s0166-3542(03)00064-0.
   PubMed Web of Science ®Google Scholar
• Wutzler P, De Clercq E, Wutke K, et al. Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial. J Med Virol. 1995;46(3):252–257. doi: 10.1002/jmv.1890460315.
   PubMed Web of Science ®Google Scholar
• Wassilew SW, Wutzler P. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study. Antiviral Res. 2003;59(1):49–56. doi: 10.1016/s0166-3542(03)00065-2.
   PubMed Web of Science ®Google Scholar
• Mao F, Wu Z, Zhang L, et al. Therapeutic effect of brivudine on 37 cases of herpes zoster. Mod Pract Med. 2018;30(04):535–536.
   Google Scholar
• Zhang X, Su B, Wang L. Observation of curative effect of brivudine on herpes zoster. Eval Anal Drug Use Hosp China. 2013;13(03):255–256. doi: 10.14009/j.issn.1672-2124.2013.03.003.
   Google Scholar
• Cheng H, Zhang D, Song T, et al. Efficacy observation and safety evaluation of brivudine in the treatment of herpes zoster. J Med Aesthet Cosmetol. 2021;30(14):80–81.
   Google Scholar
• Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(2):192. doi: 10.3390/v14020192.
   PubMed Web of Science ®Google Scholar
• Gross GE, Eisert L, Doerr HW, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia. J Dtsch Dermatol Ges. 2020;18(1):55–78. doi: 10.1111/ddg.14013.
   Web of Science ®Google Scholar
• Hassan STS, Šudomová M, Mazurakova A, et al. Insights into antiviral properties and molecular mechanisms of non-flavonoid polyphenols against human herpesviruses. Int J Mol Sci. 2022;23(22):2022. doi: 10.3390/ijms232213891.
   PubMed Web of Science ®Google Scholar
• Kenzaka T, Sugimoto K, Goda K, et al. Acute kidney injury and acyclovir-associated encephalopathy after administration of valacyclovir in an elderly person with normal renal function: a case report and literature review. Medicine. 2021;100(21):e26147. doi: 10.1097/md.0000000000026147.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Takemoto M, Daikoku T. Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment. Expert Rev Anti Infect Ther. 2021;19(11):1415–1425. doi: 10.1080/14787210.2021.1917992.
   PubMed Web of Science ®Google Scholar
• Werner RN, Nikkels AF, Marinović B, et al. European consensus-based (S2k) guideline on the management of herpes zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), part 2: treatment. J Eur Acad Dermatol Venereol. 2017;31(1):20–29. doi: 10.1111/jdv.13957.
   PubMed Web of Science ®Google Scholar
• García Herrera AN, Moncayola Vicén JC. [Lethal interaction between 5-fluorouracil and brivudine]. An Sist Sanit Navar. 2018;41(2):277–278. doi: 10.23938/assn.0297.
   PubMed Web of Science ®Google Scholar
• Andrei G, Snoeck R, Reymen D, et al. Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus. Eur J Clin Microbiol Infect Dis. 1995;14(4):318–329. doi: 10.1007/bf02116525.
   PubMed Web of Science ®Google Scholar
• Laskin OL, Longstreth JA, Saral R, et al. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in ­humans. Antimicrob Agents Chemother. 1982;21(3):393–398. doi: 10.1128/aac.21.3.393.
   PubMed Web of Science ®Google Scholar
• Rabasseda X. Brivudine: a herpes virostatic with rapid antiviral activity and once-daily dosing. Drugs Today. 2003;39(5):359–371. doi: 10.1358/dot.2003.39.5.740221.
   PubMed Web of Science ®Google Scholar
• McDonald EM, de Kock J, Ram FS. Antivirals for management of herpes zoster including ophthalmicus: a systematic review of high-quality randomized controlled trials. Antivir Ther. 2012;17(2):255–264. doi: 10.3851/imp2011.
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic eye disease study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 2020;127(4s):S5–S18. doi: 10.1016/j.ophtha.2020.01.037.
   PubMedGoogle Scholar